In A Nutshell Johns Hopkins researchers developed a blood test that catches 81% of stage IA lung cancers (the earliest, most ...

Screening and cycle 1, day 1 (C1D1) pretreatment samples from 132 previously untreated and 228 previously treated patients in the FLAURA and AURA3 trials ...

Lung cancer varies widely from patient to patient, and that diversity makes it hard to find effective treatments. Researchers ...

Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified why certain lung cancer cells ...

Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...

A recent study reveals significant progress in biomarker testing for lung cancer in community settings, highlighting the need ...

Small cell lung cancer, or SCLC, is aggressive, lethal and particularly cruel because chemotherapy initially works so well. But within just a few months, SCLC becomes resistant to drugs and dashes ...

A newly identified metabolite in human feces improves immunotherapy and could radically change the treatment of lung cancer.

Cancer immunotherapy has been a game-changer, but many tumors still find ways to slip past the immune system. New research ...

Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified why certain lung cancer cells become highly resistant to treatment after developing mutations in a key gene ...